日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Nanoparticle-formulated mRNA encoding engineered multivalent SIRPα-Fc fusion proteins shows robust anti-cancer activity in preclinical models.

纳米颗粒制剂的 mRNA 编码工程化的多价 SIRPα-Fc 融合蛋白在临床前模型中显示出强大的抗癌活性

Lal Shruti, Sallets Adrienne, Bandi Srinivasa R, Adusumilli Gowrisudha, Liu Weiqun, Low Ray, Ferry Kimmy, MacDonough Chris, ElAzzouny Mahmoud, Haabeth Ole A W, McKinlay Colin J, Hsu Pei-Ken, Sharma Anushtha, Dhungel Pragyesh, Triplett Jenna, Leong Meredith, McCartney-Melstad Evan, Deutsch Samuel, Gunasekaran Kannan

NTX250: A Modular mRNA-Based Immunotherapy Platform for HPV-Associated Cancers with Broad Applicability.

NTX250:一种具有广泛适用性的模块化 mRNA 免疫治疗平台,用于治疗 HPV 相关癌症。

Leong Meredith L, Liu Weiqun, Fay Nicole, Da Silva Diane M, Li Ou, Rae Chris S, Sallets Adrienne, Prins Ruben, Frimannsson Daniel, McKinlay Colin, Low Ray, Fernandez Daniel J, Kannan Gunasekaran, Dhungel Pragyesh, Nath Sangeeta, Peck Nicole E, Webster Elizabeth R, Wen Ximiao, Sharma Anushtha, Lemmens Edward E, Deutsch Samuel, Kast W Martin, Haabeth Ole Audun W